Date published: 2026-4-23

1-800-457-3801

SCBT Portrait Logo
Seach Input

Syntaxin Activators

Syntaxin Activators, in the context of specific chemical compounds, play a crucial role in modulating the functional activity of Syntaxin, a key protein in vesicle fusion and neurotransmitter release. Compounds like 4-Aminopyridine and Tetraethylammonium chloride enhance neurotransmitter release by blocking voltage-gated potassium channels. This action indirectly increases Syntaxin-mediated vesicle fusion and release by prolonging action potentials and altering neuronal excitability. Similarly, Bafilomycin A1, by inhibiting V-ATPase and affecting vesicular acidification, can enhance Syntaxin's role in neurotransmitter release by changing vesicle dynamics. Furthermore, calcium channel blockers like Omega-conotoxin GVIA, Nifedipine, Verapamil, Cadmium chloride, anhydrous, ω-Agatoxin IVA, and ω-Conotoxin MVIIC indirectly influence Syntaxin's role in calcium-dependent neurotransmitter release. These compounds modulate calcium influx, a critical trigger for vesicle fusion and release, thereby impacting Syntaxin's functionality. In particular, the inhibition of various types of calcium channels leads to altered intracellular calcium dynamics, which is fundamental in regulating Syntaxin-mediated exocytosis.

Additionally, Clostridium botulinum neurotoxin type A and Botulinum Toxin type B are included for their specific inhibitory effects on components of the SNARE complex. These toxins indirectly enhance Syntaxin's role by altering the dynamics of vesicle fusion and neurotransmitter release, providing a unique perspective on how Syntaxin's activity can be modulated. Concanavalin A, by binding to mannose-containing glycoproteins, may influence Syntaxin's interaction with other SNARE proteins, further affecting its function in vesicle fusion. Collectively, these chemical compounds, through their diverse mechanisms, indirectly augment Syntaxin's activity, highlighting the complex interplay of ion channels, toxins, and other molecular entities in the regulation of neurotransmitter release and neuronal communication.

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

4-Aminopyridine

504-24-5sc-202421
sc-202421B
sc-202421A
25 g
1 kg
100 g
$38.00
$1155.00
$122.00
3
(2)

Enhances neurotransmitter release by blocking voltage-gated potassium channels, which can indirectly increase Syntaxin-mediated vesicle fusion and release.

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$98.00
$255.00
$765.00
$1457.00
280
(6)

Inhibits V-ATPase, affecting vesicular acidification and potentially enhancing Syntaxin's role in neurotransmitter release by altering vesicle dynamics.

Tetraethylammonium chloride

56-34-8sc-202834
25 g
$45.00
2
(1)

Blocks voltage-gated potassium channels, potentially enhancing Syntaxin's activity in vesicle fusion and neurotransmitter release by prolonging action potentials.

Concanavalin A

11028-71-0sc-203007
sc-203007A
sc-203007B
50 mg
250 mg
1 g
$119.00
$364.00
$947.00
17
(2)

Binds to mannose-containing glycoproteins, potentially influencing Syntaxin's interaction with other SNARE proteins and its function in vesicle fusion.

Nifedipine

21829-25-4sc-3589
sc-3589A
1 g
5 g
$59.00
$173.00
15
(1)

Blocks L-type calcium channels, indirectly affecting Syntaxin-mediated neurotransmitter release by modulating calcium influx.

Verapamil

52-53-9sc-507373
1 g
$374.00
(0)

Inhibits L-type calcium channels, potentially enhancing Syntaxin's role in vesicle fusion and neurotransmitter release by altering intracellular calcium dynamics.

Cadmium chloride, anhydrous

10108-64-2sc-252533
sc-252533A
sc-252533B
10 g
50 g
500 g
$56.00
$183.00
$352.00
1
(1)

Inhibits calcium channels, indirectly influencing Syntaxin-mediated neurotransmitter release by affecting calcium signaling.

ω-Agatoxin IVA

145017-83-0sc-302015
100 µg
$463.00
(0)

Blocks P/Q-type calcium channels, indirectly affecting Syntaxin's role in neurotransmitter release.